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A corrigendum on
A validated model of the pro- and anti-inflammatory cytokine balancing act in articular
cartilage lesion formation
by Wang, X., Brouillette, M. J., Ayati, B. P., and Martin, J. A. (2015). Front. Bioeng. Biotechnol. 3:25.
doi: 10.3389/fbioe.2015.00025
There are a number of errors in the originalmanuscript (Wang et al., 2015) due to the use of incorrect
versions of our material during the final manuscript preparation stage. They are
1. Figure 1has the incorrect schematic. The figure in this corrigendum is the schematic thatmatches
the models and simulations in the manuscript.
FIGURE 1 | Schematic of the articular cartilage lesion formation
process due to a single blunt impact.
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2. In equation (1b), U should be U.
3. The correct initial condition for ROS is R(r, 0)= 0.
4. The Heaviside function is defined incorrectly in equation (2).
We use the standard Heaviside function, H()= 1 for  0,
H()= 0 for  < 0.
5. In equations (5a) and (6b), the Monod functions that depend
on ROS, R, should instead depend on DAMPs,M.
6. The parameter  in equations (8a) and (9) should be 1.
7. The underbraces in equations (8a), (8b), and (9) that indi-
cate dependence on TNF- specifically should instead indicate
dependence on a generic pro-inflammatory cytokine, denoted
by F.
8. Equation (8b) does not depend on CU. In place of CU in the
equation there should instead be implicit multiplication by 1.
9. In Table 2, the correct parameter value for F is 0.1664 and the
correct parameter value for P is 0.5545. These were obtained
from the derivation in (Wang et al., 2014):
F =   24100 hour ln

1
2

= 0:1664=day; (1)
P =   2430 hour ln

1
2

= 0:5545=day: (2)
Here 100 hours is the approximate half-life of TNF-
(Wedlock et al., 1996; Brines and Cerami, 2008) and
30 hours is the approximate half-life of DAMPs and EPO
(Ito et al., 2008). To obtain the half-lives from the source
literature, we used the “N-end Rule” (Varshavsky, 1997).
The similarities in their half-lives are why we have that
M = P. We note that the parameter values in Table 1
of (Wang et al., 2014) are not consistent with the cor-
rect values in the body of the text (Wang et al., 2014,
pg. 931).
All the simulations in the original manuscript where conducted
with these versions of the equations and parameters.
Acknowledgments
The authors thank Georgi Kapitanov for a careful reading of the
manuscript and source code. Funding: XW, BA, MB, and JM were
partially supported by NIAMS grant #1 P50 AR055533. MB was
supported by a Merit Review Award from the Department of
Veterans Affairs.
References
Brines, M., and Cerami, A. (2008). Erythropoietin-mediated tissue protection:
reducing collateral damage from the primary injury response. J. Intern. Med.
264, 405–432. doi:10.1111/j.1365-2796.2008.02024.x
Ito, T., Kawahara, K., Okamoto, K., Yamada, S., Yasuda, M., Imaizumi, H., et al.
(2008). Proteolytic cleavage of high mobility group box 1 protein by thrombin-
thrombomodulin complexes. Arterioscler. Thromb. Vasc. Biol. 28, 1825–1830.
doi:10.1161/ATVBAHA.107.150631
Varshavsky, A. (1997). The N-end rule pathway of protein degradation. Genes Cells
2, 13–28. doi:10.1046/j.1365-2443.1997.1020301.x
Wang, X., Ayati, B. P., Brouillete, M. J., Graham, J. M., Ramakrishnan, P. S., and
Martin, J. A. (2014). Modeling and simulation of the effects of cyclic loading
on articular cartilage lesion formation. Int. J. Numer. Method Biomed. Eng. 30,
927–941. doi:10.1002/cnm.2636
Wang, X., Brouillette, M. J., Ayati, B. P., and Martin, J. A. (2015). A validated
model of the pro- and anti-inflammatory cytokine balancing act in articular
cartilage lesion formation. Front. Bioeng. Biotechnol. 3:25. doi:10.3389/fbioe.
2015.00025
Wedlock, D. N., Aldwell, F. E., and Buddle, B. M. (1996). Molecular cloning and
characterization of tumor necrosis factor alpha (TNF-alpha) from the Aus-
tralian common brushtail possum, Trichosurus vulpecula. Immunol. Cell Biol.
74, 151–158. doi:10.1038/icb.1996.20
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2015 Wang, Brouillette, Ayati and Martin. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org May 2015 | Volume 3 | Article 732
